About: Orphan drugs Archives
-
Italy’s pharma scandal heats up drugs pricing debate
The European Consumer Organisation (BEUC) has urged the European Commission to investigate pharma-industry “unethical” practices on drug pricing, after a scandal revealed last week in Italy.
-
EU health ministers confront crisis in affordability of medicines
EU health ministers took reluctant steps last Friday (17 June) to address the rising price of medicines.
-
INFOGRAPHIC: Rare diseases in the EU
Rare diseases affect more than 30 million Europeans, many of whom are children! What is the European Union doing about it?
-
€144 million earmarked for new research on rare diseases
The European Commission will provide €144 million of new funding for 26 research projects, with the objective to deliver 200 new therapies for rare diseases by 2020, the EU's executive announced today (28 February).
-
Study finds orphan drugs economically viable
Orphan drugs, pharmaceutical agents that are developed specifically to treat rare diseases, have the potential to generate as much lifetime revenue as drugs used for more common health conditions, according to a new study.
